Resolution No. 108-5-12Title: Evaluation of International Pharmacy Educational Programs in Consideration of Mutual RecognitionAction: Pass Whereas, the National Association of Boards of Pharmacy’s (NABP) membership includes international jurisdictions from Australia, Canada, and New Zealand; and Whereas, certain state boards of pharmacy recognize that graduates of Canadian Council for Accreditation of Pharmacy Programs-accredited programs demonstrate comparable competency […]

Read More ›

Resolution No. 108-6-12Title: Regulation of Pharmacy Benefit ManagersAction: Pass Whereas, the activities of pharmacy benefit managers may not be specifically addressed in federal or state statutes and regulations; and Whereas, the absence of specific federal and state regulations may leave patients without any mechanism to report concerns and problems with the activities of and pharmacy […]

Read More ›

Resolution No. 108-7-12Title: Prescriber Dispensing or Prescriber Drug OutletsAction: Pass Whereas, state boards of pharmacy have long been, and continue to be, the sole agencies authorized by state legislatures to regulate the dispensing and distribution of drugs into and in the state by registering and licensing dispensers and dispensing drug outlets; and Whereas, boards of […]

Read More ›

Resolution No. 108-8-12Title: Repackaging Requirements for Long-Term Care FacilitiesAction: Pass Whereas, patients residing in long-term care facilities often possess prescriptions dispensed from traditional community pharmacies in containers such as capped vials; and Whereas, the United States Food and Drug Administration (FDA) has determined that transferring medications from these previously dispensed containers to unit dose packaging […]

Read More ›

Resolution No. 108-9-12Title: Drug Return and Reuse ProgramsAction: Pass Whereas, a number of state legislatures have enacted laws that allow for the return and reuse of previously dispensed prescriptions under certain conditions; and Whereas, many of these laws require boards of pharmacy to adopt rules to implement these return and reuse programs; and Whereas, many […]

Read More ›

Resolution No. 108-10-12Title: Practice of Pharmacy in Virtual Environments Across JurisdictionsAction: Pass Whereas, the growth of electronic data sharing, communication, and security has created the ability to practice pharmacy in virtual environments across jurisdictions and outside the walls of traditional pharmacies, and boards of pharmacy require leadership in developing compliance and safety processes to protect […]

Read More ›

Resolution No. 108-11-12Title: Awareness of Public Health Hazards Related to the Use of Prescription Drugs in Non-Health Care SettingsAction: Pass Whereas, there is a significant increase in the use of prescription drugs in non-health care settings including, but not limited to, the medical spa industry, which has led to practices that may endanger the public […]

Read More ›

Resolution No. 108-12-12Title: Recognition ResolutionAction: Pass Whereas, the individuals listed here have made significant contributions to the National Association of Boards of Pharmacy (NABP), the protection of the public health, and the practice of pharmacy: Marilyn M. Barron (MA)Robert Blair (WV)Leonard J. “Len” DeMino (MD)Sydnie Mae Durand (LA)Ross Holiman (AR)R.E. Post, Jr (TX)Rufus Sadler (SC)Joe […]

Read More ›

Resolution No: 109-1-13Title: Pharmacy Compounding of Sterile ProductsAction: Pass WHEREAS, the patient need for compounded medications has increased and pharmacists compounding safe and effective medications of the required quality for their patients is necessary; and WHEREAS, shortages of critical, lifesaving prescription medication have resulted in the increased demand for compounded medications by pharmacists; and WHEREAS, in […]

Read More ›

Resolution No:109-2-13Title: Prescription Medication Distribution – The Five Percent Rule for ResaleAction: PASS WHEREAS, state and federal safeguards, statutes, and regulations for the United States distribution system for prescription drugs secure against adulterated, misbranded, and counterfeit drugs; WHEREAS, despite the systems in place to secure the drug distribution system from such adulterated, misbranded, and counterfeit […]

Read More ›